Literature DB >> 25156898

N-acetylcysteine administration confers lung protection in different phases of lung ischaemia-reperfusion injury.

Luiz Felipe Forgiarini1, Luiz Alberto Forgiarini2, Darlan Pase da Rosa2, Mariel Barbachan E Silva2, Rodrigo Mariano2, Artur de Oliveira Paludo2, Cristiano Feijó Andrade3.   

Abstract

OBJECTIVES: To verify the effects of N-acetylcysteine (NAC) administered before and after ischaemia in an animal model of lung ischaemia-reperfusion (IR) injury.
METHODS: Twenty-four Wistar rats were subjected to an experimental model of selective left pulmonary hilar clamping for 45 min followed by 2 h of reperfusion. The animals were divided into four groups: control group (SHAM), ischaemia-reperfusion, N-acetylcysteine-preischaemia (NAC-Pre) and NAC-postischaemia (NAC-Post). We recorded the haemodynamic parameters, blood gas analysis and histology. We measured the thiobarbituric acid reactive substances concentration; the expression of superoxide dismutase (SOD), inducible nitric oxide synthase (iNOS), nitrotyrosine, cleaved caspase 3, nuclear factor κB (NF-κB), NF-kappa-B inhibitor alpha (IκB-α), tumour necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β); myeloperoxidase activity (MPO).
RESULTS: No significant differences were observed in the haemodynamic parameters, blood gas analysis and SOD activity among the groups. Lipid peroxidation was significantly higher in the IR and NAC-Pre groups (P < 0.01). The expression of nitrotyrosine, cleaved caspase 3, NF-κB, IκB-α, TNF-α and IL-1β were significantly higher in the IR group when compared with the SHAM and NAC groups (P < 0.01). The NAC-Pre group showed a significantly higher expression of these proteins when compared with the SHAM and NAC-Post groups (P < 0.05). After reperfusion, the expression of iNOS increased almost uniformly in all groups when compared with the SHAM group (P < 0.01). The histological analysis showed fewer inflammatory cells in the NAC groups.
CONCLUSIONS: The intravenous administration of NAC demonstrated protective properties against lung IR injury. The use of NAC immediately after reperfusion potentiates its protective effects.
© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Inflammation; Ischaemia–reperfusion; N-Acetylcysteine

Mesh:

Substances:

Year:  2014        PMID: 25156898     DOI: 10.1093/icvts/ivu258

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  6 in total

Review 1.  Mechanisms of lung ischemia-reperfusion injury.

Authors:  Victor E Laubach; Ashish K Sharma
Journal:  Curr Opin Organ Transplant       Date:  2016-06       Impact factor: 2.640

Review 2.  Oxidative Stress and Lung Ischemia-Reperfusion Injury.

Authors:  Renata Salatti Ferrari; Cristiano Feijó Andrade
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

3.  RC-3095, a selective gastrin-releasing peptide receptor antagonist, does not protect the lungs in an experimental model of lung ischemia-reperfusion injury.

Authors:  Vera L Oliveira-Freitas; Leonardo Dalla Giacomassa Rocha Thomaz; Lucas Elias Lise Simoneti; Christiane Malfitano; Kátia De Angelis; Jane Maria Ulbrich; Gilberto Schwartsmann; Cristiano Feijó Andrade
Journal:  Biomed Res Int       Date:  2015-03-29       Impact factor: 3.411

4.  Assessment of expressions of Bcl-XL, b-FGF, Bmp-2, Caspase-3, PDGFR-α, Smad1 and TGF-β1 genes in a rat model of lung ischemia/reperfusion.

Authors:  Hasan Şimşek; Şeniz Demiryürek; Tuncer Demir; Hüsne Didem Atabay; Ali Osman Çeribasi; Recep Bayraktar; Davut Sinan Kaplan; Serdar Öztuzcu; Beyhan Cengiz
Journal:  Iran J Basic Med Sci       Date:  2016-02       Impact factor: 2.699

5.  N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial.

Authors:  Qianwen Zhang; Yuanrong Ju; Yan Ma; Tao Wang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

6.  Resolvin D1 mitigates energy metabolism disorder after ischemia-reperfusion of the rat lung.

Authors:  Qifeng Zhao; Ji Wu; Qingwang Hua; Zhiyong Lin; Leping Ye; Weixi Zhang; Guowei Wu; Jie Du; Jie Xia; Maoping Chu; Xingti Hu
Journal:  J Transl Med       Date:  2016-03-24       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.